Results 231 to 240 of about 2,436,024 (405)

The Role of Non-coding RNAs in Oncology

Cell, 2019
F. Slack, A. Chinnaiyan
semanticscholar   +1 more source

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer

Molecular Oncology, EarlyView.
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui, Matthew A. Cottam, Muhammad Bilal Mirza, Keeli B. Lewis, Kristen K. Ciombor, Mary Kay Washington, Kamran Idrees   +6 more
wiley   +1 more source

Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer. [PDF]

J Clin Med
Nuransoy Cengiz A, Bozkurt O, Cengiz M, Ozkan M, Inanc M, Kefeli U, Cabuk D, Erman M, Kilickap S, Koseci T, Bayir D, Guven DC, Urun M, Cosar R, Sakalar T, Majidova N, Mutlu Ozkan E, Akosman C, Ersoy M, Sahin E, Can Sanci P, Yildiz C, Kolemen E, Agdas G, Kocaaslan E, Turkoğlu E, Yildirim S, Mermit Ercek B, Karakayali A, Arvas H, Kidi MM, Biter S, Yesil Cinkir H, Karahan L, Apaydin Rollas AE.   +34 more
europepmc   +1 more source

Radiation Oncology

Sarcoma, 2001
openaire   +2 more sources

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

The Lancet Oncology, 2020
M. Guckenberger, Y. Lievens, A. B. Bouma, L. Collette, A. Dekker, N. deSouza, A. Dingemans, B. Fournier, C. Hurkmans, F. Lecouvet, I. Meattini, A. M. Romero, U. Ricardi, N. Russell, Daniel H. Schanne, M. Scorsetti, B. Tombal, D. Verellen, C. Verfaillie, P. Ost   +19 more
semanticscholar   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son, Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo, Paola Roa, Nickole Sigcha‐Coello, Yi Liao, Eric B. Haura, Alexander Drilon, John M. Koomen, Emiliano Cocco, Uwe Rix   +13 more
wiley   +1 more source

Retraction: Effects of gallotannin-enriched extract of Galla Rhois on the activation of apoptosis, cell cycle arrest, and inhibition of migration ability in LLC1 cells and LLC1 tumors

Pathology and Oncology Research
Pathology and Oncology Research Editorial Office
doaj   +1 more source

Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer. [PDF]

Bladder Cancer
Kaufmann E, Aeppli S, Affentranger A, Arnold N, Arnold W, Aschwanden F, Balermpas P, Beyer J, Bieri U, Boormanns J, Cathomas R, Bari B, Dressler M, Engeler DS, Erdmann A, Gallina A, Gomez S, Guckenberger M, Herrmann T, Hermanns T, Lucca I, John H, Kessler TM, Klein J, Laouiti M, Lauffer D, Lerner SP, Mattei A, Müntener M, Nguyen D, Niederberger P, Papachristofilou A, Prause L, Putora PM, Reinhardt K, Salati E, Sèbe P, Shelan M, Sigg S, Strebel RT, Templeton AJ, Vogl U, Wettstein MS, Wyler S, Zihler D, Zilli T, Zwahlen D, Roth B, Fankhauser CD.   +48 more
europepmc   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Correction: Targeting immuno-oncology metabolism for precision cancer therapy. [PDF]

Front Oncol
Pajai S, John JE, Tripathi SC.
europepmc   +1 more source